IGF-I/IGF-1 Protein, Human (70a.a)
Based on 27 publication(s) in Google Scholar
IGF-I/IGF-1 Protein is an insulin-like growth factor that possesses both growth-promoting and metabolic-regulating functions. IGF-I/IGF-1 Protein is also a neurotrophic factor with neuroprotective and neuroplasticity-regulating activities. IGF-I/IGF-1 Protein plays a key role in growth and development, cell proliferation, metabolic regulation and other aspects. IGF-I/IGF-1 protein, Human (70a.a) is a recombinant IGF-I/IGF-1 protein expressed by E. coli without a tag.
- Species: Human
- Source: E. coli
-
Storage:Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
Biological Activity
Description
IGF-I/IGF-1 Protein is an insulin-like growth factor that possesses both growth-promoting and metabolic-regulating functions. IGF-I/IGF-1 Protein is also a neurotrophic factor with neuroprotective and neuroplasticity-regulating activities. IGF-I/IGF-1 Protein plays a key role in growth and development, cell proliferation, metabolic regulation and other aspects. IGF-I/IGF-1 protein, Human (70a.a) is a recombinant IGF-I/IGF-1 protein expressed by E. coli without a tag[1][2][3][4].
Background
IGF system has been demonstrated to regulate the growth of numerous tissues, such as neural tissue, lymphoid tissue, reproductive tissue, smooth muscle, endothelium, and bone. IGF-I/IGF-1, a key growth factor involved in cell growth, differentiation, survival, and cell cycle regulation, is secreted by mature osteoblasts, stored in the bone matrix, and released during bone resorption. The mitogenic effect of IGF-I/IGF-1 is mediated through its binding to IGF plasma membrane receptors. IGF-I/IGF-1 can stimulate osteoblast proliferation and differentiation, and also promote neuronal survival[1][2][3][4].
In Vitro
IGF-I/IGF-1 protein (Human; 50 ng/mL; 48 h) can activate the PI3K/Akt/mTOR signaling pathway and alleviate the apoptosis induced by 5-Heptadecylresorcinol (AR-C17; HY-N2673) in MCF-7 cells[3].
In Vivo
IGF-I/IGF-1 Protein (Human; 0.3-10 μg/day; intraventricular infusion; 7 days) exerts a neuroprotective effect in a mouse model of traumatic brain injury, promoting hippocampal neurogenesis and improving motor and cognitive functions[4].
Verified Bioactivity
1.ED50 is < 5 ng/mL, measured by a cell proliferation assay using FDC-P1 cells, corresponding to a specific activity of > 2.0×105 units/mg.
2.Measured in a serum-free cell proliferation assay using MCF-7 human breast cancer cells. The ED50 for this effect is < 5 ng/mL.
Publications (27)
-
Journal Impact Factor
-
Most Recent
-
Cell Discov
2024 Jul 2;10(1):72. PMID: 38956027 -
Adv Sci (Weinh)
IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome. [Abstract]2026 Mar 12:e20455. PMID: 41816941 -
Adv Sci (Weinh)
Inhibition of Tumor Lipogenesis and Growth by Peptide-Based Targeting of SREBP Activation. [Abstract]2025 Sep 17:e08111. PMID: 40959854
IGF-I/IGF-1 Protein, Human (70a.a) purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Sep 17:e08111. [Abstract]
Following pretreatment with Insig1/2 loop 1 peptide (15 µm) and IGF1 stimulation (100 ng/mL; 8 h), Huh7 cells were subjected to immunofluorescence analysis.
IGF-I/IGF-1 Protein, Human (70a.a) purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Sep 17:e08111. [Abstract]
Quantitative PCR analysis of SREBP1 target gene GPAM in Huh7 cells pretreated with Insig1/2 loop 1 peptide (15 µM) and stimulated with IGF1 (100 ng/mL; 10 h) .
IGF-I/IGF-1 Protein, Human (70a.a) purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Sep 17:e08111. [Abstract]
Intracellular triglyceride (TG) content was quantified in Huh7 cells pretreated with Insig1/2 loop 1 peptide (25 µM) and stimulated with IGF1 (100 ng/mL; 24 h) .
IGF-I/IGF-1 Protein, Human (70a.a) purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Sep 17:e08111. [Abstract]
Cell proliferation was assessed by automated cell counting of IGF1 stimulation (100 ng/mL; 72 h) in Huh7 cells pretreated with Insig1/2 loop 1 peptide (25 µM) for 1 h.
-
Adv Sci (Weinh)
The Nuclear Localization of ACLY Guards Early Embryo Development Through Recruiting P300 and HAT1 to Promote Histone Acetylation and Transcription. [Abstract]2025 Aug;12(31):e14367. PMID: 40470746 -
Adv Sci (Weinh)
Wnt Inhibition Safeguards Porcine Embryonic Stem Cells From the Acquisition of Extraembryonic Endoderm Cell Fates. [Abstract]2025 May;12(17):e2416802. PMID: 40063421 -
Biomaterials
LDH nanoparticles-doped cellulose nanofiber scaffolds with aligned microchannels direct high-efficiency neural regeneration and organized neural circuit remodeling through RhoA/Rock/Myosin II pathway. [Abstract]2025 Mar:314:122873. PMID: 39369670 -
Cell Death Dis
Histocompatibility Minor 13 (HM13), targeted by miR-760, exerts oncogenic role in breast cancer by suppressing autophagy and activating PI3K-AKT-mTOR pathway. [Abstract]2022 Sep 25;13(8):728. PMID: 36153332 -
Phytomedicine
A multiple-targets alkaloid nuciferine overcomes paclitaxel-induced drug resistance in vitro and in vivo. [Abstract]2020 Dec:79:153342. PMID: 32992085 -
Int J Nanomedicine
Royal Jelly-Derived Extracellular Vesicles: Key Bioactive Components Mediating Anti-Hepatocellular Carcinoma Activity. [Abstract]2026 Jun 3:21:609268. PMID: 42261358 -
EMBO Mol Med
Isoginkgetin antagonizes ALS pathologies in its animal and patient iPSC models via PINK1-Parkin-dependent mitophagy. [Abstract]2025 Oct 15. PMID: 41094045 -
Stem Cell Res Ther
Extrachromosomal circular DNAs in the differentiation of human bone marrow mesenchymal stem cells. [Abstract]2025 Jul 18;16(1):383. PMID: 40682088 -
Cell Rep
Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis. [Abstract]2022 Dec 20;41(12):111834. PMID: 36543142
IGF-I/IGF-1 Protein, Human (70a.a) purchased from MedChemExpress. Usage Cited in: Cell Rep. 2022 Dec 20;41(12):111834. [Abstract]
The phosphorylation of IGF-1R and coIP of c-Cbl and IGF-1R with anti-IGF-1R polyclonal antibody in the presence of or absence of IGF-1 (100 ng/mL) without FBS in the culture media.
-
Mol Cell Proteomics
Region-Resolved Integrative Multi-Omic Characterization Reveals Diverse Tumor and Microenvironment Features of Pituitary Neuroendocrine Tumors. [Abstract]2026 Jun;25(6):101583. PMID: 42119924 -
Int Immunopharmacol
DPEP1 mediates regulation of mitochondrial quality control via FOXO1/ALDH1L2 axis to attenuate ferroptosis in pulmonary endothelial cells to alleviate sepsis-associated acute lung injury. [Abstract]2026 Feb 1:170:116049. PMID: 41421227 -
Int J Mol Sci
Integrating Network Pharmacology, Machine Learning, and Experimental Validation to Elucidate the Mechanism of Cardamonin in Treating Idiopathic Pulmonary Fibrosis. [Abstract]2025 Dec 25;27(1):249. PMID: 41516127 -
Int Immunopharmacol
2025 Feb 6:147:113955. PMID: 39746275 -
Front Cell Dev Biol
Network Pharmacology and Experimental Validation Reveal the Effects of Chidamide Combined With Aspirin on Acute Myeloid Leukemia-Myelodysplastic Syndrome Cells Through PI3K/AKT Pathway. [Abstract]2021 Sep 9:9:685954. PMID: 34568314 -
Eur J Pharm Sci
IGF-1 inhibits inflammation and accelerates angiogenesis via Ras/PI3K/IKK/NF-κB signaling pathways to promote wound healing. [Abstract]2024 Sep 1:200:106847. PMID: 38972611 -
Front Biosci (Landmark Ed)
The Role of THBS4 in Chronic Kidney Disease Fibrosis: From Clinical Observations to Molecular Mechanisms. [Abstract]2025 Jul 29;30(7):26076. PMID: 40765330 -
-
J Pharm Pharmacol
Ethyl 2,2-difluoro-2-(2-oxo-2H-chromen-3-yl) acetate attenuates the malignant biological behaviors of non-small cell lung cancer via suppressing EGFR/PI3K/AKT/mTOR signaling pathway. [Abstract]2024 Mar 4;76(3):269-282. PMID: 38241189 -
J Cancer
Lasalocid inhibits melanoma by down-regulating FOXM1 through PI3K/AKT and JNK/P38 MAPK pathways. [Abstract]2025 Jan 1;16(3):765-783. PMID: 39781349 -
Exp Eye Res
Niclosamide inhibits TGF-β1-induced fibrosis of human Tenon's fibroblasts by regulating the MAPK-ERK1/2 pathway. [Abstract]2023 Oct:235:109628. PMID: 37619828 -
-
Exp Ther Med
Oncogenic role of LYN in human gastric cancer via the Wnt/β-catenin and AKT/mTOR pathways. [Abstract]2020 Jul;20(1):646-654. PMID: 32509024 -
Oncol Lett
PLEK2 promotes osteosarcoma tumorigenesis and metastasis by activating the PI3K/AKT signaling pathway. [Abstract]2021 Jul;22(1):534. PMID: 34084215 -
Technical Parameters
-
Species Human
-
Source E. coli
-
Tag Tag Free
-
Accession
P05019-1 (G49-A118)
-
Molecular Construction
-
N-term
-
IGF1 (G49-A118)
Accession # P05019-1 -
C-term
-
-
Protein Length
Full Length of Isoform-1
-
Synonyms
IGF1; Somatomedin-C; Insulin Like Growth Factor 1; IGF1A; IGF-I; MGF; Insulin-Like Growth Factor 1; Insulin-Like Growth Factor IB; Insulin-Like Growth Factor I; Insulin-Like Growth Factor-I; IGFI; Alternative Protein IGF1; IGF; Somatomedin C; Insulin-Like
-
AA Sequence
GPETLCGAELVDALQFVCGDRGFYFNKPTGYGSSSRRAPQTGIVDECCFRSCDLRRLEMYCAPLKPAKSA
-
Molecular Weight
Approximately 8-9 kDa, based on SDS-PAGE under reducing conditions.
-
Purity
≥ 95%, as determined by reducing SDS-PAGE.
Product Properties
Lyophilized powder
1.Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.
2.Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4, 8% trehalose.
Please refer to the lot-specific COA for specific buffer information.
<1 EU/μg, determined by LAL method.
It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O. For long term storage it is recommended to add a carrier protein (0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose).
Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
Room temperature in continental US; may vary elsewhere.
Documentation
-
Data Sheet (263 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
[1]. Richman C, et al. Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo. Endocrinology. 1999 Oct;140(10):4699-705. [Content Brief]
[2]. Zhang R, et al. Effects of TGF-beta1 and IGF-1 on proliferation of human nucleus pulposus cells in medium with different serum concentrations. J Orthop Surg Res. 2006 Oct 26;1:9. [Content Brief]
[4]. Carlson SW, et al. Central Infusion of Insulin-Like Growth Factor-1 Increases Hippocampal Neurogenesis and Improves Neurobehavioral Function after Traumatic Brain Injury. J Neurotrauma. 2018 Jul 1;35(13):1467-1480. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)